nodes	percent_of_prediction	percent_of_DWPC	metapath
Entecavir—Immunodeficiency—Methotrexate—muscle cancer	0.0546	0.0546	CcSEcCtD
Entecavir—Hepatic cirrhosis—Methotrexate—muscle cancer	0.0494	0.0494	CcSEcCtD
Entecavir—Ascites—Dactinomycin—muscle cancer	0.0481	0.0481	CcSEcCtD
Entecavir—Ascites—Etoposide—muscle cancer	0.0348	0.0348	CcSEcCtD
Entecavir—Lactic acidosis—Doxorubicin—muscle cancer	0.0336	0.0336	CcSEcCtD
Entecavir—Hepatomegaly—Dactinomycin—muscle cancer	0.0309	0.0309	CcSEcCtD
Entecavir—Laboratory test abnormal—Doxorubicin—muscle cancer	0.0196	0.0196	CcSEcCtD
Entecavir—Ascites—Doxorubicin—muscle cancer	0.0181	0.0181	CcSEcCtD
Entecavir—Hepatic failure—Dactinomycin—muscle cancer	0.0177	0.0177	CcSEcCtD
Entecavir—Hepatic failure—Vincristine—muscle cancer	0.0158	0.0158	CcSEcCtD
Entecavir—Transaminases increased—Doxorubicin—muscle cancer	0.0135	0.0135	CcSEcCtD
Entecavir—Serum creatinine increased—Doxorubicin—muscle cancer	0.0133	0.0133	CcSEcCtD
Entecavir—Neutropenia—Dactinomycin—muscle cancer	0.0128	0.0128	CcSEcCtD
Entecavir—Anaphylactoid reaction—Etoposide—muscle cancer	0.0119	0.0119	CcSEcCtD
Entecavir—Hepatomegaly—Doxorubicin—muscle cancer	0.0116	0.0116	CcSEcCtD
Entecavir—Neutropenia—Vincristine—muscle cancer	0.0115	0.0115	CcSEcCtD
Entecavir—Hepatitis—Dactinomycin—muscle cancer	0.011	0.011	CcSEcCtD
Entecavir—Glycosuria—Doxorubicin—muscle cancer	0.0101	0.0101	CcSEcCtD
Entecavir—Alopecia—Dactinomycin—muscle cancer	0.0097	0.0097	CcSEcCtD
Entecavir—Neutropenia—Etoposide—muscle cancer	0.00928	0.00928	CcSEcCtD
Entecavir—Renal failure—Etoposide—muscle cancer	0.0087	0.0087	CcSEcCtD
Entecavir—Alopecia—Vincristine—muscle cancer	0.00867	0.00867	CcSEcCtD
Entecavir—Mental disorder—Vincristine—muscle cancer	0.00859	0.00859	CcSEcCtD
Entecavir—Leukopenia—Dactinomycin—muscle cancer	0.00855	0.00855	CcSEcCtD
Entecavir—Hepatobiliary disease—Etoposide—muscle cancer	0.00837	0.00837	CcSEcCtD
Entecavir—Infection—Dactinomycin—muscle cancer	0.00775	0.00775	CcSEcCtD
Entecavir—Hepatic failure—Methotrexate—muscle cancer	0.00765	0.00765	CcSEcCtD
Entecavir—Leukopenia—Vincristine—muscle cancer	0.00764	0.00764	CcSEcCtD
Entecavir—Immune system disorder—Etoposide—muscle cancer	0.00717	0.00717	CcSEcCtD
Entecavir—Anaphylactoid reaction—Methotrexate—muscle cancer	0.00711	0.00711	CcSEcCtD
Entecavir—Alopecia—Etoposide—muscle cancer	0.00702	0.00702	CcSEcCtD
Entecavir—Anaphylactic shock—Vincristine—muscle cancer	0.00697	0.00697	CcSEcCtD
Entecavir—Infection—Vincristine—muscle cancer	0.00692	0.00692	CcSEcCtD
Entecavir—Nervous system disorder—Vincristine—muscle cancer	0.00683	0.00683	CcSEcCtD
Entecavir—Fatigue—Dactinomycin—muscle cancer	0.00672	0.00672	CcSEcCtD
Entecavir—Hepatic failure—Doxorubicin—muscle cancer	0.00663	0.00663	CcSEcCtD
Entecavir—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00638	0.00638	CcSEcCtD
Entecavir—Insomnia—Vincristine—muscle cancer	0.0063	0.0063	CcSEcCtD
Entecavir—Leukopenia—Etoposide—muscle cancer	0.00619	0.00619	CcSEcCtD
Entecavir—Abdominal pain—Dactinomycin—muscle cancer	0.00616	0.00616	CcSEcCtD
Entecavir—Body temperature increased—Dactinomycin—muscle cancer	0.00616	0.00616	CcSEcCtD
Entecavir—Anaphylactoid reaction—Doxorubicin—muscle cancer	0.00615	0.00615	CcSEcCtD
Entecavir—Gastrointestinal disorder—Vincristine—muscle cancer	0.00601	0.00601	CcSEcCtD
Entecavir—Fatigue—Vincristine—muscle cancer	0.00601	0.00601	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00585	0.00585	CcSEcCtD
Entecavir—Pancreatitis—Methotrexate—muscle cancer	0.00583	0.00583	CcSEcCtD
Entecavir—Gastrointestinal pain—Vincristine—muscle cancer	0.0057	0.0057	CcSEcCtD
Entecavir—Anaphylactic shock—Etoposide—muscle cancer	0.00564	0.00564	CcSEcCtD
Entecavir—Infection—Etoposide—muscle cancer	0.00561	0.00561	CcSEcCtD
Entecavir—Asthenia—Dactinomycin—muscle cancer	0.00559	0.00559	CcSEcCtD
Entecavir—Blood creatinine increased—Doxorubicin—muscle cancer	0.00558	0.00558	CcSEcCtD
Entecavir—Neutropenia—Methotrexate—muscle cancer	0.00556	0.00556	CcSEcCtD
Entecavir—Upper respiratory tract infection—Methotrexate—muscle cancer	0.00552	0.00552	CcSEcCtD
Entecavir—Abdominal pain—Vincristine—muscle cancer	0.00551	0.00551	CcSEcCtD
Entecavir—Body temperature increased—Vincristine—muscle cancer	0.00551	0.00551	CcSEcCtD
Entecavir—Skin disorder—Etoposide—muscle cancer	0.00548	0.00548	CcSEcCtD
Entecavir—Abdominal pain upper—Doxorubicin—muscle cancer	0.00544	0.00544	CcSEcCtD
Entecavir—Diarrhoea—Dactinomycin—muscle cancer	0.00534	0.00534	CcSEcCtD
Entecavir—Renal failure—Methotrexate—muscle cancer	0.00521	0.00521	CcSEcCtD
Entecavir—Haematuria—Methotrexate—muscle cancer	0.00505	0.00505	CcSEcCtD
Entecavir—Pancreatitis—Doxorubicin—muscle cancer	0.00505	0.00505	CcSEcCtD
Entecavir—Somnolence—Etoposide—muscle cancer	0.00502	0.00502	CcSEcCtD
Entecavir—Hepatobiliary disease—Methotrexate—muscle cancer	0.00501	0.00501	CcSEcCtD
Entecavir—Asthenia—Vincristine—muscle cancer	0.005	0.005	CcSEcCtD
Entecavir—Vomiting—Dactinomycin—muscle cancer	0.00496	0.00496	CcSEcCtD
Entecavir—Rash—Dactinomycin—muscle cancer	0.00492	0.00492	CcSEcCtD
Entecavir—Gastrointestinal disorder—Etoposide—muscle cancer	0.00487	0.00487	CcSEcCtD
Entecavir—Fatigue—Etoposide—muscle cancer	0.00487	0.00487	CcSEcCtD
Entecavir—Neutropenia—Doxorubicin—muscle cancer	0.00481	0.00481	CcSEcCtD
Entecavir—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.00478	0.00478	CcSEcCtD
Entecavir—Diarrhoea—Vincristine—muscle cancer	0.00477	0.00477	CcSEcCtD
Entecavir—Hepatitis—Methotrexate—muscle cancer	0.00476	0.00476	CcSEcCtD
Entecavir—Hyperglycaemia—Doxorubicin—muscle cancer	0.00464	0.00464	CcSEcCtD
Entecavir—Nausea—Dactinomycin—muscle cancer	0.00463	0.00463	CcSEcCtD
Entecavir—Gastrointestinal pain—Etoposide—muscle cancer	0.00461	0.00461	CcSEcCtD
Entecavir—Dizziness—Vincristine—muscle cancer	0.00461	0.00461	CcSEcCtD
Entecavir—Renal failure—Doxorubicin—muscle cancer	0.00451	0.00451	CcSEcCtD
Entecavir—Abdominal pain—Etoposide—muscle cancer	0.00446	0.00446	CcSEcCtD
Entecavir—Body temperature increased—Etoposide—muscle cancer	0.00446	0.00446	CcSEcCtD
Entecavir—Vomiting—Vincristine—muscle cancer	0.00443	0.00443	CcSEcCtD
Entecavir—Rash—Vincristine—muscle cancer	0.00439	0.00439	CcSEcCtD
Entecavir—Dermatitis—Vincristine—muscle cancer	0.00439	0.00439	CcSEcCtD
Entecavir—Haematuria—Doxorubicin—muscle cancer	0.00438	0.00438	CcSEcCtD
Entecavir—Headache—Vincristine—muscle cancer	0.00436	0.00436	CcSEcCtD
Entecavir—Hepatobiliary disease—Doxorubicin—muscle cancer	0.00434	0.00434	CcSEcCtD
Entecavir—Immune system disorder—Methotrexate—muscle cancer	0.0043	0.0043	CcSEcCtD
Entecavir—Alopecia—Methotrexate—muscle cancer	0.0042	0.0042	CcSEcCtD
Entecavir—Mental disorder—Methotrexate—muscle cancer	0.00417	0.00417	CcSEcCtD
Entecavir—Malnutrition—Methotrexate—muscle cancer	0.00414	0.00414	CcSEcCtD
Entecavir—Nausea—Vincristine—muscle cancer	0.00414	0.00414	CcSEcCtD
Entecavir—Hepatitis—Doxorubicin—muscle cancer	0.00412	0.00412	CcSEcCtD
Entecavir—Oedema peripheral—Doxorubicin—muscle cancer	0.00406	0.00406	CcSEcCtD
Entecavir—Asthenia—Etoposide—muscle cancer	0.00405	0.00405	CcSEcCtD
Entecavir—Diarrhoea—Etoposide—muscle cancer	0.00386	0.00386	CcSEcCtD
Entecavir—Dizziness—Etoposide—muscle cancer	0.00373	0.00373	CcSEcCtD
Entecavir—Immune system disorder—Doxorubicin—muscle cancer	0.00372	0.00372	CcSEcCtD
Entecavir—Leukopenia—Methotrexate—muscle cancer	0.00371	0.00371	CcSEcCtD
Entecavir—Alopecia—Doxorubicin—muscle cancer	0.00364	0.00364	CcSEcCtD
Entecavir—Mental disorder—Doxorubicin—muscle cancer	0.00361	0.00361	CcSEcCtD
Entecavir—Vomiting—Etoposide—muscle cancer	0.00359	0.00359	CcSEcCtD
Entecavir—Malnutrition—Doxorubicin—muscle cancer	0.00359	0.00359	CcSEcCtD
Entecavir—Rash—Etoposide—muscle cancer	0.00356	0.00356	CcSEcCtD
Entecavir—Dermatitis—Etoposide—muscle cancer	0.00355	0.00355	CcSEcCtD
Entecavir—Headache—Etoposide—muscle cancer	0.00354	0.00354	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.0035	0.0035	CcSEcCtD
Entecavir—Anaphylactic shock—Methotrexate—muscle cancer	0.00338	0.00338	CcSEcCtD
Entecavir—Infection—Methotrexate—muscle cancer	0.00336	0.00336	CcSEcCtD
Entecavir—Nausea—Etoposide—muscle cancer	0.00335	0.00335	CcSEcCtD
Entecavir—Nervous system disorder—Methotrexate—muscle cancer	0.00332	0.00332	CcSEcCtD
Entecavir—Skin disorder—Methotrexate—muscle cancer	0.00328	0.00328	CcSEcCtD
Entecavir—Leukopenia—Doxorubicin—muscle cancer	0.00321	0.00321	CcSEcCtD
Entecavir—Insomnia—Methotrexate—muscle cancer	0.00306	0.00306	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.00303	0.00303	CcSEcCtD
Entecavir—Somnolence—Methotrexate—muscle cancer	0.00301	0.00301	CcSEcCtD
Entecavir—Dyspepsia—Methotrexate—muscle cancer	0.00298	0.00298	CcSEcCtD
Entecavir—Anaphylactic shock—Doxorubicin—muscle cancer	0.00293	0.00293	CcSEcCtD
Entecavir—Gastrointestinal disorder—Methotrexate—muscle cancer	0.00292	0.00292	CcSEcCtD
Entecavir—Fatigue—Methotrexate—muscle cancer	0.00291	0.00291	CcSEcCtD
Entecavir—Infection—Doxorubicin—muscle cancer	0.00291	0.00291	CcSEcCtD
Entecavir—Nervous system disorder—Doxorubicin—muscle cancer	0.00287	0.00287	CcSEcCtD
Entecavir—Skin disorder—Doxorubicin—muscle cancer	0.00284	0.00284	CcSEcCtD
Entecavir—Gastrointestinal pain—Methotrexate—muscle cancer	0.00276	0.00276	CcSEcCtD
Entecavir—Abdominal pain—Methotrexate—muscle cancer	0.00267	0.00267	CcSEcCtD
Entecavir—Body temperature increased—Methotrexate—muscle cancer	0.00267	0.00267	CcSEcCtD
Entecavir—Insomnia—Doxorubicin—muscle cancer	0.00265	0.00265	CcSEcCtD
Entecavir—Somnolence—Doxorubicin—muscle cancer	0.0026	0.0026	CcSEcCtD
Entecavir—Dyspepsia—Doxorubicin—muscle cancer	0.00258	0.00258	CcSEcCtD
Entecavir—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.00253	0.00253	CcSEcCtD
Entecavir—Fatigue—Doxorubicin—muscle cancer	0.00252	0.00252	CcSEcCtD
Entecavir—Asthenia—Methotrexate—muscle cancer	0.00243	0.00243	CcSEcCtD
Entecavir—Gastrointestinal pain—Doxorubicin—muscle cancer	0.00239	0.00239	CcSEcCtD
Entecavir—Abdominal pain—Doxorubicin—muscle cancer	0.00231	0.00231	CcSEcCtD
Entecavir—Body temperature increased—Doxorubicin—muscle cancer	0.00231	0.00231	CcSEcCtD
Entecavir—Diarrhoea—Methotrexate—muscle cancer	0.00231	0.00231	CcSEcCtD
Entecavir—Dizziness—Methotrexate—muscle cancer	0.00224	0.00224	CcSEcCtD
Entecavir—Vomiting—Methotrexate—muscle cancer	0.00215	0.00215	CcSEcCtD
Entecavir—Rash—Methotrexate—muscle cancer	0.00213	0.00213	CcSEcCtD
Entecavir—Dermatitis—Methotrexate—muscle cancer	0.00213	0.00213	CcSEcCtD
Entecavir—Headache—Methotrexate—muscle cancer	0.00212	0.00212	CcSEcCtD
Entecavir—Asthenia—Doxorubicin—muscle cancer	0.0021	0.0021	CcSEcCtD
Entecavir—Nausea—Methotrexate—muscle cancer	0.00201	0.00201	CcSEcCtD
Entecavir—Diarrhoea—Doxorubicin—muscle cancer	0.002	0.002	CcSEcCtD
Entecavir—Dizziness—Doxorubicin—muscle cancer	0.00194	0.00194	CcSEcCtD
Entecavir—Vomiting—Doxorubicin—muscle cancer	0.00186	0.00186	CcSEcCtD
Entecavir—Rash—Doxorubicin—muscle cancer	0.00185	0.00185	CcSEcCtD
Entecavir—Dermatitis—Doxorubicin—muscle cancer	0.00184	0.00184	CcSEcCtD
Entecavir—Headache—Doxorubicin—muscle cancer	0.00183	0.00183	CcSEcCtD
Entecavir—Nausea—Doxorubicin—muscle cancer	0.00174	0.00174	CcSEcCtD
